Literature DB >> 17884636

Chemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.

Aaron T Wright1, Benjamin F Cravatt.   

Abstract

The cytochrome P450 (P450) superfamily metabolizes many endogenous signaling molecules and drugs. P450 enzymes are regulated by posttranslational mechanisms in vivo, which hinders their functional characterization by conventional genomic or proteomic methods. Here we describe a chemical proteomic strategy to profile P450 activities directly in living systems. Derivatization of a mechanism-based inhibitor with a "clickable" handle provided an activity-based probe that labels multiple P450s both in proteomic extracts and in vivo. This probe was used to record alterations in liver P450 activities triggered by chemical agents, including inducers of P450 expression and direct P450 inhibitors. The chemical proteomic strategy described herein thus offers a versatile method to monitor P450 activities and small-molecule interactions in any biological system and, through doing so, should facilitate the functional characterization of this large and diverse enzyme class.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884636      PMCID: PMC2044501          DOI: 10.1016/j.chembiol.2007.08.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  52 in total

1.  Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

Authors:  K Venkatakrishnan; L L von Moltke; M H Court; J S Harmatz; C L Crespi; D J Greenblatt
Journal:  Drug Metab Dispos       Date:  2000-12       Impact factor: 3.922

Review 2.  Study of P450 function using gene knockout and transgenic mice.

Authors:  Frank J Gonzalez; Shioko Kimura
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

3.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

Authors:  Thorir D Bjornsson; John T Callaghan; Heidi J Einolf; Volker Fischer; Lawrence Gan; Scott Grimm; John Kao; S Peter King; Gerald Miwa; Lan Ni; Gondi Kumar; James McLeod; R Scott Obach; Stanley Roberts; Amy Roe; Anita Shah; Fred Snikeris; John T Sullivan; Donald Tweedie; Jose M Vega; John Walsh; Steven A Wrighton
Journal:  Drug Metab Dispos       Date:  2003-07       Impact factor: 3.922

Review 4.  Function of human cytochrome P450s: characterization of the orphans.

Authors:  F Peter Guengerich; Zhong-Liu Wu; Cheryl J Bartleson
Journal:  Biochem Biophys Res Commun       Date:  2005-08-22       Impact factor: 3.575

5.  Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling.

Authors:  Michael J Evans; Alan Saghatelian; Erik J Sorensen; Benjamin F Cravatt
Journal:  Nat Biotechnol       Date:  2005-10-02       Impact factor: 54.908

Review 6.  Mechanism-based profiling of enzyme families.

Authors:  Michael J Evans; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

7.  Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.

Authors:  T Chang; M Levine; G D Bellward
Journal:  J Pharmacol Exp Ther       Date:  1992-03       Impact factor: 4.030

8.  Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.

Authors:  T Chang; M Levine; S M Bandiera; G D Bellward
Journal:  J Pharmacol Exp Ther       Date:  1992-03       Impact factor: 4.030

Review 9.  Cytochrome P450 enzymes: novel options for cancer therapeutics.

Authors:  Morag C E McFadyen; William T Melvin; Graeme I Murray
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

Review 10.  Cigarette smoking, metabolic activation and carcinogenesis.

Authors:  Akiyoshi Nishikawa; Yukio Mori; In-Seon Lee; Takuji Tanaka; Masao Hirose
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

View more
  32 in total

1.  Exploiting Substrate Promiscuity To Develop Activity-Based Probes for Ten-Eleven Translocation Family Enzymes.

Authors:  Uday Ghanty; Jamie E DeNizio; Monica Yun Liu; Rahul M Kohli
Journal:  J Am Chem Soc       Date:  2018-12-11       Impact factor: 15.419

2.  On the mechanism of dimethylarginine dimethylaminohydrolase inactivation by 4-halopyridines.

Authors:  Corey M Johnson; Arthur F Monzingo; Zhihong Ke; Dae-Wi Yoon; Thomas W Linsky; Hua Guo; Jon D Robertus; Walter Fast
Journal:  J Am Chem Soc       Date:  2011-06-23       Impact factor: 15.419

Review 3.  The role of targeted chemical proteomics in pharmacology.

Authors:  Chris W Sutton
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

5.  How chemoproteomics can enable drug discovery and development.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2012-01-27

6.  Pyrethroid activity-based probes for profiling cytochrome P450 activities associated with insecticide interactions.

Authors:  Hanafy M Ismail; Paul M O'Neill; David W Hong; Robert D Finn; Colin J Henderson; Aaron T Wright; Benjamin F Cravatt; Janet Hemingway; Mark J I Paine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

7.  A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells.

Authors:  Melissa M Yatzeck; Luke D Lavis; Tzu-Yuan Chao; Sunil S Chandran; Ronald T Raines
Journal:  Bioorg Med Chem Lett       Date:  2008-06-10       Impact factor: 2.823

8.  Click Triazoles for Bioconjugation.

Authors:  Tianqing Zheng; Sara H Rouhanifard; Abubakar S Jalloh; Peng Wu
Journal:  Top Heterocycl Chem       Date:  2012

Review 9.  Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platforms.

Authors:  Daniel Medina-Cleghorn; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-09-18

10.  Role of Cytochrome P450 Hydroxylase in the Decreased Accumulation of Vitamin E in Muscle from Turkeys Compared to that from Chickens.

Authors:  Dale M Perez; Mark P Richards; Robert S Parker; Mark E Berres; Aaron T Wright; Mamduh Sifri; Natalie C Sadler; Nantawat Tatiyaborworntham; Na Li
Journal:  J Agric Food Chem       Date:  2016-01-12       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.